A Wegovy pen that leaks, stops unexpectedly, or seems not to activate creates two questions: what happened to the device, and what to do about the prescription. Those questions have different owners. A pharmacist or manufacturer can investigate a product problem; the prescribing clinician needs to advise about an uncertain dose. Do not decide on another injection by estimating a wet patch, counting clicks, or comparing appetite with last week. The amount delivered cannot be reconstructed reliably from those observations alone.
This guide concerns the US single-dose Wegovy injection device described in the linked manufacturer instructions. A pen with a dose dial, a different national presentation, a multi-dose device, a vial, and an oral tablet are not interchangeable. Start with the exact product on your own dispensing label. The pen-versus-vial guide explains why a familiar medicine name does not identify the delivery system. A device problem is a reason to get specific help, not to adapt instructions from another product.
What the manufacturer actually says
The manufacturer describes an injection window and explains that the second click does not by itself mean the injection is finished. Its troubleshooting instructions say that medicine appearing on the skin or squirting from the needle can mean the full dose was not received; the injection cannot be restarted, and the healthcare professional should advise what to do. That is the important boundary. A possible partial dose is neither a confirmed full dose nor a confirmed zero dose.[1]
Read the instructions supplied with your actual pack rather than treating this article as a substitute demonstration. If the written steps are hard to follow, ask the pharmacist or clinical team to review the device with you before a future injection. A useful demonstration identifies the exact presentation and lets you explain the steps back in your own words. It should not turn into advice to alter the pen, dismantle it, transfer its contents, or use a spare device to compensate for an uncertain amount.
Describe the event without diagnosing the pen
Write down what you directly observed while it is still fresh: whether you had begun the injection, whether the indicator moved, whether there was visible liquid, and whether the device was removed before you expected completion. Include the date and approximate time. A simple sequence is more useful than the conclusion that the pen was defective. A product complaint can involve a device fault, handling difficulty, packaging damage, or a mix-up; describing the sequence leaves the investigation open.
If you have a photograph that can be taken safely, it may help show the package label or visible condition. Do not recreate the event to obtain a better photograph. Do not expose or handle a used needle for documentation. Ask the pharmacist or manufacturer how to preserve or return any device they need to inspect. Keeping information is sensible; keeping an exposed sharp in an unsafe place is not. The separate sharps-disposal article covers the safety side of used injection equipment.
The packaging details can resolve the wrong question
Have the dispensing label, product strength, lot number, expiration date, and pharmacy contact information available when you call. A lot identifies a manufacturing batch; a pharmacy prescription number identifies your dispensing record. Both may help, but they do different jobs. Also note whether the problem concerns one pen or an unopened package. Avoid publishing photographs of labels that expose your name, address, prescription number, or other personal information in a public forum.
The goal is to let the person reviewing the problem establish that everyone is discussing the same presentation and prescription. For example, an order confirmation can describe a requested strength while the actual box describes what arrived. A problem with what was shipped needs a dispensing review even before anyone interprets the mechanics. FDA treats product mix-ups, defective components, packaging concerns, and device malfunctions as legitimate product-quality issues to report.[2]
Contact the pharmacy and the clinical team
Tell the dispensing pharmacy that you have an uncertain injection or suspected product problem, rather than asking only for a refill. Ask how the issue will be recorded and whether the manufacturer needs information from the original pack. Separately tell the prescriber what happened and when, including whether any medicine may have entered. If you have symptoms or have already taken an additional injection, say that clearly. An administrative replacement conversation should not delay clinical advice about a possible dosing error.
When choosing ongoing care, ask who answers a device question outside a scheduled appointment and how the pharmacy and prescriber communicate. Our Ro review and PlushCare review offer background for comparing care arrangements; their presence here is not a promise of a replacement, a particular response time, or coverage of your prescription. The relevant question is the support included in the actual service you use. A general sales chat is not necessarily the team making a prescribing decision.
A manufacturer complaint is not a treatment plan
Novo Nordisk provides separate channels for customer support, adverse-event reporting, and product complaints. Use the current US contact page or the information supplied with your medicine so that you reach the appropriate product and country team. Record a case number if one is supplied and ask what further information is needed. This article does not establish that a voucher, refund, replacement box, or return kit will be offered in a particular case.[3]
A favorable replacement decision answers how a product issue will be handled commercially. It does not decide when to use the replacement or whether it is appropriate after an uncertain injection. Likewise, an insurer approving another fill does not establish a new dosing schedule. Keep those decisions separate in your notes. If you receive two different answers, ask the clinical team to reconcile them with the actual prescription rather than following whichever answer arrived most recently.
Make the follow-up answer usable
A helpful reply should identify the exact question it answers. If the pharmacy says it can order a replacement, ask whether the prescriber has also reviewed the uncertain injection. If the manufacturer says the device will be investigated, ask what you should do with the packaging while that happens. If the clinical team gives advice verbally, ask for it in the patient portal or another agreed written channel. These are practical ways to reduce crossed messages, not additional medical instructions.
Keep a short timeline of the contacts rather than trying to remember several conversations. Note the organization, date, case reference, the question asked, and any promised next step. That makes it easier to tell whether an unanswered question is clinical, a dispensing problem, or a customer-service issue. It also prevents the same story from being retold differently as it passes between teams. Share the information through their appropriate private channel, not a public review or social-media thread.
Before the next scheduled treatment discussion, explain whether this event has made you anxious about using the device. Training may need to address hand position, visibility of the indicator, or the ability to hold the device steadily, rather than simply repeating the written leaflet. Ask whether a trained support person may help with the prescribed presentation. Do not buy an unofficial adapter or change the device because an online video makes the task appear easier. The practical objective is a method you can perform correctly and confidently under the applicable instructions.
Costs deserve their own written answer. A replacement process might involve the pharmacy, a manufacturer assessment, and insurance billing, and those conversations can finish at different times. Ask what charge is being considered before authorizing a new purchase, and whether it is for a replacement product, a normal refill, or another clinical visit. Keeping the invoice question separate helps you compare the offer without allowing a payment deadline to determine a medical decision.
Reporting a suspected quality problem
FDA MedWatch accepts voluntary reports concerning product problems and medication or device-use errors, as well as adverse events. A report can be worthwhile even when the reporter cannot prove the cause. The report should distinguish the suspected problem from any injury or symptom and include the identifying details available. FDA information explains that quality concerns may arise in manufacture, shipping, or storage; a report is an input to safety oversight, not a finding that a manufacturer caused the event.[2][4]
Reporting does not replace urgent medical care, a pharmacist conversation, or a prescription decision. Nor does it itself create a refund claim or guarantee that a particular batch will be recalled. A single malfunction report and a public recall are different kinds of evidence. If someone online says all pens from a lot are defective, look for an official notice rather than treating a shared experience as a verified batch-wide conclusion.
A missed injection and an uncertain injection differ
A known missed dose means there was no injection. With leakage or an interrupted device, the delivered amount may be unknown. Those are different descriptions of what happened, and the distinction should be made clear when asking for advice. Explain the uncertainty rather than presenting an estimated amount as a confirmed missed dose. This guide deliberately does not calculate a replacement amount or give a timetable for taking another pen.
The missed-dose article explains the separate situation in which a scheduled dose was not taken. The injection-technique article addresses preparation and delivery questions. After a problem, the useful result is a documented account, clear clinical advice, and a practical plan for future device use. A successful next appointment should leave you knowing whom to contact, which instructions apply, and how the original event was resolved—not merely with another box and the same uncertainty.